Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_assertion type Assertion NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_head.
- NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_assertion description "[Administration of sodium valproate (VPA), a histone deacetylase 5 (HDAC5) inhibitor, not only significantly relieved the anxiety- and depression-like behaviors of CUS-induced rats but also clearly blunted decrease of H3(K9) and H4(K12) acetylation and expression of TH and TPH, and prevented increase of HDAC5 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_provenance.
- NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_assertion evidence source_evidence_predicted NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_provenance.
- NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_assertion SIO_000772 24495952 NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_provenance.
- NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_assertion wasDerivedFrom rgd-20150221 NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_provenance.
- NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_assertion wasGeneratedBy ECO_0000218 NP42057.RAYV_lI4rgKuqFZ2Jj2tKuwrryrcvrhCFfo0DoMyr4oJo130_provenance.